The Scientist - Home

Latest

The Scientist Placeholder Image

Maggot sleuthing

The Scientist Placeholder Image

Biotech in space?

The Scientist Placeholder Image

First Actin-binding Protein, circa 1975

The Scientist Placeholder Image

An eye on history

The Scientist Placeholder Image

Dr. Mom

The Scientist Placeholder Image

Eco-Oscars

The Scientist Placeholder Image

An orchestra that works and plays

The Scientist Placeholder Image

Beta eye-lets

The Scientist Placeholder Image

Guts to glory

The Scientist Placeholder Image

Thick bones, big drug

The Scientist Placeholder Image

Baiting Ebola

The Scientist Placeholder Image

The Mendel-Nägeli letters, circa 1866-73

Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas